Price Comparison

Dihexa

Cognitive Peptide

8 vendors competing

8 of 8 vendors
Prices for Dihexa by vendor
VendorPrice10mg costUpdatedActions
Elytra Labs7.5/10
7.5/10
COA ✓Ships: USCredit/debit card
Verification & shipping
7.5/10
COA ✓Ships: USCredit/debit card
$38.00$40.00−5% · code PEPTIDEP5100mg package$38.00Checked aug 2, 2026Aug 2, 2026Buy Dihexa from Elytra Labs
Pristine Aminos4.5/10
4.5/10
COA on requestShips: USCredit/debit card
Verification & shipping
4.5/10
COA on requestShips: USCredit/debit card
Out of stock
$65.0010mg package$65.00Checked aug 2, 2026Aug 2, 2026Buy Dihexa from Pristine Aminos
Alpha Peptides8/10
8/10
COA ✓Ships: USCredit/debit card
Verification & shipping
8/10
COA ✓Ships: USCredit/debit card
Out of stock
$35.79$39.77−10% · code PEPTIDEPRICES105mg package$71.58Checked jul 31, 2026Jul 31, 2026Buy Dihexa from Alpha Peptides
NeuroLabs8.5/10
8.5/10
COA ✓Ships: US + internationalVisa · Mastercard
Verification & shipping
8.5/10
COA ✓Ships: US + internationalVisa · Mastercard
$74.9510mg package$74.95Checked jul 31, 2026Jul 31, 2026Buy Dihexa from NeuroLabs
VoidResearch7/10
7/10
COA ✓Ships: WorldwideCryptocurrency · Zelle
Verification & shipping
7/10
COA ✓Ships: WorldwideCryptocurrency · Zelle
Out of stock
$76.50$85.00−10% · code PEPTIDEPRI10mg package$76.50Checked jul 30, 2026Jul 30, 2026Buy Dihexa from VoidResearch
Licensed Peptides8/10
8/10
COA ✓Ships: US + internationalCredit/debit card
Verification & shipping
8/10
COA ✓Ships: US + internationalCredit/debit card
$129.995% off via our link·auto10mg package$129.99Checked jun 4, 2026Jun 4, 2026Buy Dihexa from Licensed Peptides

Research details

Dihexa — research data

Half-life~24 hours (estimated). Daily dosing.
Regulatory statusNot FDA-approved
NCAA D1Not listed

Overview

About Dihexa

Mechanism of action

HGF/MET system potentiator; derived from angiotensin IV; binds hepatocyte growth factor (HGF) and prevents its degradation; activates MET receptor; promotes synaptogenesis, dendritic spine density, and neuroplasticity; ~7 orders of magnitude more potent than BDNF per unit.

Safety profile

Limited human data. Potential: overstimulation, anxiety, insomnia at high doses. Theoretical cancer concern (HGF/MET pathway implicated in tumor growth — use with caution in cancer history). · Acts via c-Met activation — a tumor-growth pathway — giving a real oncogenicity concern; no long-term or human safety data; no human trials. Generally avoided with any cancer history.

Storage

Stability & handling

❄️Lyophilized (powder)−20°Clong-term stable
💉Reconstituted2–8°Cwithin 30 days

Related pages

More on Dihexa

Stack & Compare

Frequently Researched Together

Research

Studies & key findings

  • Dihexa is an orally active, blood-brain-barrier-permeable angiotensin IV analogue that potentiates hepatocyte growth factor (HGF) signaling at the c-Met receptor; the original 2014 JPET paper (PMID 25187433) reported it induced hippocampal spinogenesis and synaptogenesis orders of magnitude more potently than BDNF — however, this paper was formally retracted in April 2025 (PMID 40312093) due to data integrity concerns, and its primary findings should not be cited as established.
  • A 2021 Brain Sciences study independent of the retracted group found that Dihexa treatment improved spatial learning and memory in APP/PS1 Alzheimer's model mice, reduced neuroinflammatory markers, and restored neuronal populations; the beneficial effects were blocked by PI3K/AKT pathway inhibitors, identifying this axis as the operative downstream mechanism.

5 peer-reviewed sources cited — clinical, preclinical, and regulatory.

Read full research →
Failed to fetch